Compelling features of a safe medication-use system

American Journal of Health-System Pharmacy

Volumn 63, Issue 15, 2006, Pages 1461-1468

  Kelly, William N ^b   Rucker, T Donald ^a  

^a National Health Ensurance   (United States)

^b William N Kelly Consulting Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ELECTROLYTE; HEPARIN; INSULIN; MORPHINE; NARCOTIC ANALGESIC AGENT; OPIATE; POTASSIUM CHLORIDE; WARFARIN;

CLINICAL PROTOCOL; COST CONTROL; DECISION SUPPORT SYSTEM; DRUG FATALITY; DRUG INFORMATION; DRUG SAFETY; ELECTRONIC MEDICAL RECORD; EMERGENCY WARD; EVIDENCE BASED MEDICINE; GOVERNMENT; HEALTH CARE SYSTEM; HEALTH ECONOMICS; HEALTH INSURANCE; HEALTH PRACTITIONER; HUMAN; INCIDENT REPORT; INFUSION SYSTEM; MEASUREMENT ERROR; MEDICAL TECHNOLOGY; MEDICATION ERROR; NOTE; PATIENT SAFETY; PHARMACIST; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT;

EID: 33747199020     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp050343     Document Type: Note

References (64)

1. Kohn LT, Corrigan JM, Donaldson MS, eds. To err is human: building a safer health system. Washington, DC: National Academy Press; 1999.
2. Committee on Quality of Health Care in America. Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academy Press; 2001.
3. Aspden P, Corrigan JM, Wolcott J et al., eds. Patient safety: achieving a new standard for care. Washington, DC: National Academy Press; 2004.
4. Berwick DM. Escape fire: designs for the future of health care. New York: Commonwealth Fund; 2002.
5. Altman DE, Clancy C, Blendon RJ. Improving patient safety-five years after the IOM report. N Engl J Med. 2004; 351:2041-3.
6. Leape LL, Berwick DM. Five years after to err is human: what have we learned? JAMA. 2005; 293:2384-90.
7. Barker KN, Flynn EA, Pepper GA et al. Medication errors observed in 36 health care facilities. Arch Intern Med. 2002; 162:1897-903.
8. Schneitman-McIntire O, Farnen TA, Gordon N et al. Medication misadventures in emergency department visits at an HMO medical center. Am J Health-Syst Pharm. 1996; 53:1416-22.
9. Dennehy CE, Kishi DT, Louie C. Drug-related illness in emergency department patients. Am J Health-Syst Pharm. 1996; 53:1422-6.
10. Gurwitz JH, Field TS, Harrold LR et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003; 289: 1107-16.
11. Ashcroft DM, Quinlan P, Blenkinsopp A. Prospective study of the incidence, nature and causes of dispensing errors in community pharmacies. Pharmacoepidemiol Drug Saf. 2005; 14:327-32.
12. Flynn EA, Barker KN, Pepper GA et al. Comparison of methods for detecting medication errors in 36 hospitals and skilled-nursing facilities. Am J Health-Syst Pharm. 2002; 59:436-46.
13. Kelly WN. Can the frequency and risks of fatal adverse drug events be determined? Pharmacotherapy. 2001; 21:521-7.
14. Kelly WN. Potential risks and prevention, part 2: drug-induced permanent disabilities. Am J Health-Syst Pharm. 2001; 58:1325-9.
15. Marcellino K, Kelly WN. Potential risks and prevention, part 3: drug-induced threats to life. Am J Health-Syst Pharm. 2001; 58:1399-405.
16. Bates DW, Spell N, Cullen DJ et al. The costs of adverse drug events in hospitalized patients. JAMA. 1997; 277:307-11.
17. Schneider PJ, Gift MG, Lee YL et al. Cost of medication-related problems at a university hospital. Am J Health-Syst Pharm. 1995; 52:2415-8.
18. Bootman JL, Harrison DL, Cox E. The health care cost of drug-related morbidity and mortality in nursing facilities. Arch Intern Med. 1997; 157:2089-96.
19. Johnson JA, Bootman JL. Drug-related morbidity and mortality: a cost-of-illness model. Arch Intern Med. 1995; 155:1949-56.
20. Kelly WN. Potential risks and prevention, part 1: fatal adverse drug events. Am J Health-Syst Pharm. 2001; 58:1317-24.
21. Rucker TD. Prescribed medications: system control or therapeutic roulette? In: Maciej N, ed. IFAC monograph: control aspects of biomedical engineering. Oxford: Permamon; 1987.
22. Leatherman S, Berwick D, Iles D et al. The business case for quality: case studies and analysis. Health Aff. 2003; 22:17-30.
23. McDonald CJ, Weiner M, Hui SL. Deaths due to medical errors are exaggerated in Institute of Medicine report. JAMA. 2000; 284:93-7. Letter.
24. Traynor K. Physicians, public not overly concerned about medical errors, www. ashp.org/news/ShowArticle.cfm?id =3227 (accessed 2003 Jan 7).
25. Gandi TK, Shojania KG, Bates DW. Protocols for high risk drugs: reducing adverse drug events related to anticoagulants. Chap. 9. In: Making healthcare safer: a critical analysis of patient safety practices. Rockville, MD: Agency for Healthcare Research and Quality; 2001.
26. Schiff GD, Rucker TD. Computerized prescribing: building the electronic infrastructure for better medication usage. JAMA. 1998; 279:1024-9.
27. Bates DW, Teich JM, Lee J et al. The impact of computerized physician order entry on medication error prevention. J Am Med Inform Assoc. 1999; 6:313-21.
28. Pedersen CA, Schneider PJ, Scheckelhoff DJ. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing-2004. Am J Health-Syst Pharm. 2005; 62:378-90.
29. Kaushal R, Bates DW. The clinical pharmacist's role in preventing adverse drug events. Chap. 7. In: Making healthcare safer: a critical analysis of patient safety practices. Rockville, MD: Agency for Healthcare Research and Quality; 2001.
30. Foli HL, Poole RL, Benitz WE et al. Medication error prevention by clinical pharmacists in two children's hospitals. Pediatrics. 1987; 79:718-22.
31. Scarsi KK, Fotis MA, Noskin GA. Pharmacist participation in medical rounds reduces medication errors. Am J Health-Syst Pharm. 2002; 59:2089-92.
32. Leape LL, Cullen DJ, Clapp MD et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999; 282:267-70.
33. Erratum, JAMA. 1999; 283:1293.
34. Lee AJ, Boro MS, Knapp KK et al. Clinical and economic outcomes of pharmacist recommendations in a Veterans Affairs medical center. Am J Health-Syst Pharm. 2002; 59:2070-7.
35. Oren E, Shaffer ER, Guglielmo BJ. Impact of emerging technologies on medication errors and adverse drug events. Am J Health-Syst Pharm. 2003; 60:1447-58.
36. Ragan R, Bond J, Major K et al. Improved control of medication use with an integrated bar-code-packaging and distribution system. Am J Health-Syst Pharm. 2005; 62:1075-9.
37. Kuyper AR. Patient counseling detects prescription errors. Hosp Pharm. 1993; 28:1180-9.
38. Medco Health Solutions. Boston area physicians embrace e-prescribing technology as a tool to improve healthcare: docs say paperless prescribing prevents errors, http://phx.corporate-ir.net/phoenix.zhtml?c=131268&p=irol- newsArticle&ID=442064&highlight= (accessed 2003 Feb 7).
39. American Society of Health-System Pharmacists. Improving medication safety in health systems through innovations in automation technology, www. ashpadvantage.com/website_images/pdf/auto_tech.pdf (accessed 2005 Jun 2).
40. Faris RJ, MacKinnon GE 3rd, MacKinnon NJ et al. Perceived importance of pharmacy management skills. Am J Health-Syst Pharm. 2005; 62:1067-72.
41. White SJ. Are you a manager or a leader? Am J Health-Syst Pharm. 2005; 62:1206.
42. Kelly WN, Seaver DJ. Strategic planning for clinical services. Am J Hosp Pharm. 1981; 38:1786-8.
43. National Coordinating Council for Medication Error Reporting and Prevention. Use of medication error rates to compare health care organizations is of no value. www.nccmerp.org/council/council2002-06-11.html (accessed 2005 Jul 11).
44. Nebeker JR, Hoffman JM, Weir CR et al. High rates of adverse drug events in a highly computerized hospital. Arch Intern Med. 2005; 165:1111-6.
45. National Coordinating Committee for Medication Error Reporting. NCC MERP index for categorizing medication errors. www.nccmerp.org/pdf/indexColor2001-06- 12.pdf (accessed 2005 Jul 11).
46. Improving patient safety through research: Almut Winterstein. ASHP Foundation News. 2005; 17(2):5.
47. Hicks RW, Cousins DD, Williams RL. Summary of information submitted to MEDMARX in the year 2002: the quest for quality. Rockville, MD: USP Center for the Advancement of Patient Safety; 2003.
48. Kelly WN. Potential risks and prevention, part 4: reports of significant adverse drug events. Am J Health-Syst Pharm. 2001; 58:1406-12.
49. Senders JW, Senders SJ. Failure mode and effects analysis in medicine. Chap. 3. In: Cohen MR, ed. Medication errors: causes, prevention, and risk management. Boston: Jones and Barlett; 2000.
50. Williams E, Talley R. The use of failure mode effect and criticality analysis in a medication error subcommittee. Hosp Pharm. 1994; 29:331-9.
51. Cohen MR, Senders J, Davis NM. Failure mode and effects analysis: a novel approach to avoiding dangerous medication errors and accidents. Hosp Pharm. 1994; 29:319-28.
52. Adachi W, Lodolce AE. Use of failure mode and effects analysis in improving the safety of i.v. drug administration. Am J Health-Syst Pharm. 2005; 62:917-20.
53. American Society of Consultant Pharmacists. Guidelines on preventing medication errors in pharmacies and long-term care facilities through reporting and evaluation. www.ascp.com/resources/policy/upload/Gui97-Med%20Errors.pdf (accessed 2005 Jun 2).
54. Bernard S. The perfect prescription. How the pill bottle was remade-sensibly and beautifully, http://newyorkmetro.com/nymetro/health/ features/11700/index.html (accessed 2005 Jun 2).
55. Mazyck P. Effects of "look-alike" and "sound alike" computer network alerts on community pharmacy dispensing errors: a randomized trial. J Manag Care Pharm. 2005; 11:269.
56. Classen DC, Pestotnik SL, Evans RS et al. Description of a computerized adverse drug event monitor using a hospital information system. Hosp Pharm. 1992; 27:774-83.
57. Gandi TK, Bates DW. Computer adverse drug event detection and alerts. Chap. 8. In: Making healthcare safer: a critical analysis of patient safety practices. Rockville, MD: Agency for Healthcare Research and Quality; 2001.
58. Al-Tajir GK, Kelly WN. Epidemiology, comparative methods of detection, and preventability of adverse drug events. Ann Pharmacother. 2005; 39: 1169-74.
59. Institute for Healthcare Improvement. Reducing adverse drug events: Missouri Baptist Medical Center. www.ihi.org/IHI/Topics/Patient Safety/MedicationSystems ImprovementStoriesReducingAd verseDrugEventsMissouriBaptist MedicalCenter.htm (accessed 2005 Jun 3).
60. Agency for Healthcare Research and Quality. Clinicians value medication safety alerts and welcome small-group training to make better use of them. www. ahrq.gov/research/jan05/0105RA10. htm (accessed 2006 Apr 26).
61. Daniels J, Kelly WN, Malone JT. Managing behavior can reduce medical and medication errors. Hospitals. In press.
62. Kelly WN. Medication errors: lessons learned and actions needed. Prof Saf. 2004; 49:35-41.
63. Gladwell M. The tipping point: how little things can make a big difference. New York: Little, Brown; 2002.
64. Kelly WN. Prescribed medication and the public health: laying the foundation for risk reduction. Binghamton, NY: Haworth; 2006.